EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators

Guowei Ma, Chuang Yang, Yonggang Chen, Ji Luo, Xiang Zhu, Jie Chen

PeerJ · 30.10.2026 · 14 · e21911

DOI: 10.7717/peerj.21911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 30.10.2026. Verfasst von Guowei Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Third People's Hospital of Kunming, Kunming, China. Hauptthemen laut MEDLINE: MicroRNAs, Chemical and Drug Induced Liver Injury, Antitubercular Agents. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific Research Project of Yunnan Clinical Medical Center, The Kunming Health Talent Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-induced liver injury (DILI) is characterized by hepatic dysfunction due to exogenous agents, potentially progressing to acute liver failure. MicroRNA-122-5p (miR-122-5p) constitutes about 70% of total liver microRNAs, offering high liver specificity and superior sensitivity for detecting injury compared to traditional transaminases, without interference from renal or muscle injury. This cross-sectional study aims to evaluate the diagnostic utility of miR-122-5p as a biomarker for anti-tuberculosis DILI. Methods miR-122-5p expression was measured by real-time quantitative polymerase chain reaction (PCR). Descriptive statistics summarized sample characteristics. For normally distributed continuous variables with equal variances, data were presented as mean ± standard deviation, with comparisons among three groups using one-way analysis of variance (ANOVA); otherwise, data were expressed as median (interquartile range) with Kruskal–Wallis H test, followed by Mann–Whitney U pairwise comparisons. Categorical variables were analyzed by Chi-square test. Receiver operating characteristic (ROC) analysis assessed diagnostic efficacy (area under the curve (AUC), optimal cutoff, sensitivity, specificity). Correlations with alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) were evaluated by Spearman’s rank correlation, and scatter plots with fitted lines were generated using Python.

Results

The DILI group showed significantly higher miR-122-5p expression (2.48 ± 0.81) than the Liver biochemical abnormality and Healthy control groups ( P < 0.001). ROC analysis yielded an AUC of 0.829 (95% confidence interval (CI) [0.732–0.926]), with sensitivity 0.833 and specificity 0.760 for distinguishing DILI from non-DILI. miR-122-5p positively correlated with ALT ( ρ = 0.626, P < 0.001) and AST ( ρ = 0.522, P < 0.001), but not with ALP ( ρ = 0.193, P = 0.114). No significant intergroup differences in age or gender were found ( P > 0.05).

Conclusions

Our research indicates that miR-122-5p has potential utility as a biomarker for anti-tuberculosis DILI, particularly in distinguishing it from healthy controls. However, these findings are exploratory, based on a small cohort with no independent validation, and its incremental value beyond conventional liver function tests remains to be determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsChemical and Drug Induced Liver InjuryAntitubercular AgentsHumansBiomarkersMaleFemaleCross-Sectional StudiesAdultMiddle AgedROC CurveLiverSensitivity and SpecificityLiver Function Tests

Stichwörter der Autor:innen

MicroRNABiomarkerDiagnosisDrug-induced liver injury

Substanzen

MicroRNAsBiomarkersMIRN122 microRNA, humanAntitubercular Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The Third People's Hospital of Kunming, Kunming, China.
  • College of Pharmacy, Dali University, Dali, China.

Förderung

  • The Scientific Research Project of Yunnan Clinical Medical Center
  • The Kunming Health Talent Training Program

Zitieren

APA

Ma, G., Yang, C., Chen, Y., Luo, J., Zhu, X., & Chen, J. (2026). Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators. PeerJ, 14, e21911. https://doi.org/10.7717/peerj.21911

Vancouver

Ma G, Yang C, Chen Y, Luo J, Zhu X, Chen J. Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators. PeerJ. 2026;14:e21911. doi:10.7717/peerj.21911

BibTeX
@article{Ma2026,
  author = {Ma, Guowei and Yang, Chuang and Chen, Yonggang and Luo, Ji and Zhu, Xiang and Chen, Jie},
  title = {Evaluating miR-122-5p as a biomarker for anti-tuberculosis drug-induced liver injury: diagnostic efficacy and correlation with liver function indicators},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21911},
  doi = {10.7717/peerj.21911}
}
Kostenlos starten →